• Build the field operations infrastructure required for future launches, including CRM set-up, territory design, account planning, targeting and segmentation, call planning, activity tracking, and field reporting.
• Design the future sales cycle and customer engagement model, including how opportunities are identified, prioritized, planned, executed, followed up, measured, and continuously improved.
• Define field force effectiveness standards, including coverage, frequency, account prioritization, productivity measures, coaching routines, incentive principles, and performance governance.
• Develop commercial operations playbooks, launch checklists, templates, dashboards, operating rhythms, and common ways of working to enable consistent execution across countries.
• Ensure sales operations processes are practical for a growing biotech environment, scalable across markets, and aligned with applicable compliance, regulatory, medical, and local market requirements.

• Establish the commercial governance model for Europe, including decision rights, escalation paths, performance review forums, business planning routines, and cross-functional launch readiness meetings.
• Partner with Legal, Compliance, Medical, Regulatory, HR, Finance, and Global Commercialization to develop and implement the foundational commercial policies required before launch.
• Define policies and standards for customer engagement, field activity, CRM use, promotional material processes, meeting governance, samples or materials where applicable, sponsorships, congress interactions, and documentation requirements.
• Ensure all policies and processes are embedded through training, communication, monitoring, and continuous improvement, with clear ownership between regional and country teams.

• Build commercial analytics, forecasting, market research and business insights, and performance management capabilities to support data-driven decision-making from pre-launch through post-launch execution.
• Develop executive dashboards and KPI frameworks covering launch readiness, field activity, customer engagement, business performance, market dynamics, sales cycle progression, and operational execution.
• Partner with Finance, Market Access, Data/Digital/AI, and country teams to support forecasting, resource allocation, scenario planning, and performance review processes.
• Identify commercial risks, opportunities, capability gaps, and operational bottlenecks, translating insights into clear recommendations and practical action plans for regional and country leadership.

• Master’s degree or equivalent advanced qualification in Life Sciences, Medicine, Pharmacy, Business Administration, Marketing, Strategy, or a related discipline.
• MBA, PhD, MD, or other postgraduate qualification is preferred, particularly where combined with strong commercial leadership experience in oncology or specialty care.
• Additional executive education in strategy, marketing, general management, digital transformation, or healthcare leadership is an advantage.

• Extensive senior leadership experience in pharmaceutical, biotechnology, or specialty care commercial operations, commercial excellence, sales operations, or launch excellence.
• Significant experience building or scaling commercial infrastructure across multiple European markets, ideally in an organization preparing for its first launches or major commercial expansion.
• Strong expertise in sales force effectiveness, CRM implementation, territory design, targeting and segmentation, account planning, field reporting, incentive principles, and commercial performance governance.
• Proven experience establishing launch readiness frameworks, commercial policies, sales processes, operating rhythms, dashboards, and cross-functional governance in a matrixed environment.
• Experience working closely with Global Commercialization, General Managers, Market Access, Medical Affairs, Regulatory, Legal, Compliance, Finance, HR, Data/Digital/AI, and country leadership teams.
• Strong record of influencing senior stakeholders, clarifying accountabilities, balancing global direction with local market realities, and creating scalable ways of working across countries.
• Oncology experience is preferred, particularly in environments where commercial capabilities, teams, systems, and processes have needed to be built from the ground up.

• Strategic and operational leader who can move seamlessly from enterprise-level commercial design to practical implementation in markets.
• Builder mindset, comfortable creating structure, processes, tools, governance, and clarity in a fast-growing organization where many elements do not yet exist.
• Highly collaborative and influential, with the ability to align Global, regional, and country stakeholders around common standards while respecting local market needs.
• Commercially sharp, analytically strong, pragmatic, and execution-oriented, with a strong focus on measurable impact and continuous improvement.
• High integrity, sound judgment, and strong commitment to compliant, ethical, patient-focused, and cross-functional ways of working.

The proposed gross annual base salary range for this position, in the primary location, based on a full-time schedule is:

CHF244,000.00---366,000.00

The final salary offer will depend on several factors, including your skills, qualifications, and experience.

In addition to base salary, this position is eligible for additional forms of compensation, such as discretionary bonuses and long-term incentives.

When you join Genmab, you become a part of a culture that supports your physical, financial, social, and emotional well-being. Our benefits include, but are not limited to:

• Pension
• Health insurance and wellness benefits
• Paid time off
• Employee support programs

Further details on eligibility for compensation and benefits based on the role will be provided during the recruitment process.

Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators, and effector function-enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with an international presence across North America, Europe, and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X.

Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com).

Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year. If the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the contract.